12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Somatuline Depot regulatory update

In its earnings for FY11 ended March 31, Teijin said that in September it filed an application in Japan for ITM-014 to treat acromegaly. Ipsen markets the extended-release injectable...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >